What's new? Log in Free sign up

Azenta (AZTA) News and press releases

Company Profile

News

From Benzinga Pro

Top 5 Health Care Stocks That May Rocket Higher In Q1 2023

Long Ideas, News, Small Cap, Pre-Market Outlook, Markets, Trading Ideas

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Top 5 Health Care Stocks That Could Blast Off This Month

Long Ideas, News, Small Cap, Pre-Market Outlook, Markets, Trading Ideas

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

6 Analysts Have This to Say About Azenta

Analyst Ratings

B. Riley Securities Maintains Buy on Azenta, Lowers Price Target to $68

News, Price Target, Analyst Ratings

B. Riley Securities analyst Yuan Zhi maintains Azenta (NASDAQ:AZTA) with a Buy and lowers the price target from $77 to $68.

Analysts Says Azenta Could See Recovery, Stock Likely Rangebound

Analyst Color, Earnings, Large Cap, News, Downgrades, Health Care, Price Target, Reiteration, Analyst Ratings, Movers, General

Benzinga's Top Ratings Upgrades, Downgrades For February 9, 2023

Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings

Stephens & Co. Downgrades Azenta to Equal-Weight, Lowers Price Target to $60

News, Downgrades, Price Target, Analyst Ratings

Stephens & Co. analyst Jacob Johnson downgrades Azenta (NASDAQ:AZTA) from Overweight to Equal-Weight and lowers the price target from $65 to $60.

Needham Maintains Buy on Azenta, Lowers Price Target to $68

News, Price Target, Analyst Ratings

Needham analyst David Saxon maintains Azenta (NASDAQ:AZTA) with a Buy and lowers the price target from $78 to $68.

12 Health Care Stocks Moving In Wednesday's After-Market Session

Azenta Q1 EPS $0.12 Beats $0.08 Estimate, Sales $178.37M Miss $181.73M Estimate

Azenta (NASDAQ:AZTA) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.08 by 50 percent. This is unchanged from the same period last year. The company reported quarterly

Needham Reiterates Buy on Azenta, Maintains $78 Price Target

News, Price Target, Reiteration, Analyst Ratings

Needham analyst David Saxon reiterates Azenta (NASDAQ:AZTA) with a Buy and maintains $78 price target.

Earnings Scheduled For February 8, 2023

Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is likely to report earnings for its fourth quarter. • Bunge (NYSE:BG) is projected to report quarterly earnings at $3.22 per share on revenue of $18.22 billion.

A Preview Of Azenta's Earnings

Exagen Inc. Elects Tina S. Nova, Ph.D. As Executive Chair Of The Board Of Directors

News, Management

Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, announced today that Tina S. Nova, Ph.D. has been elected as Executive Chair of the Exagen Board of Directors, effective January 19,

What To Know About Evercore ISI Group's Downgrade of Azenta

Analyst Ratings

Evercore ISI Group Downgrades Azenta to In-Line, Raises Price Target to $62

News, Downgrades, Price Target, Analyst Ratings

Evercore ISI Group analyst Vijay Kumar downgrades Azenta (NASDAQ:AZTA) from Outperform to In-Line and raises the price target from $60 to $62.

Press releases

From Benzinga Pro

Azenta to Participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

BURLINGTON, Mass., March 15, 2023 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that Company management will participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on

Azenta Publishes its Environmental, Social, & Governance (ESG) Report

Commodities, Press Releases

BURLINGTON, Mass., March 7, 2023 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced the publication of its Environmental, Social, & Governance ("ESG") report, highlighting the Company's ongoing

Azenta to Participate in Upcoming Investor Conferences

BURLINGTON, Mass., Feb. 28, 2023 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that Company management will participate in two upcoming investor conferences: Cowen 43rd Annual Health Care Conference in

Azenta Launches Cryo Store Pico™, a Novel Automated Cryogenic Storage System Designed for Clinical and Laboratory Applications

An Extension of Azenta's Innovative and Market Leading Automated Cryogenic Technology BURLINGTON, Mass., Feb. 27, 2023 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced the launch of the Cryo Store

Azenta to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

BURLINGTON, Mass., Feb. 10, 2023 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that Company management will participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on

Azenta Reports First Quarter Results For Fiscal 2023, Ended December 31, 2022

Earnings, Press Releases

Reported Q1'23 Revenue of $178 Million and Growth of 28% Year-Over-YearDelivered Organic Growth Excluding COVID of 7%Reducing Cost Structure to Deliver Two Points of Margin Enhancement in 2nd Half FY23BURLINGTON,

Azenta Announces Fiscal 2023 First Quarter Earnings Conference Call and Webcast

BURLINGTON, Mass., Feb. 6, 2023 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) will announce fiscal first quarter 2023 earnings which ended on December 31, 2022 on Wednesday, February 8, 2023 after the market closes. The

Azenta Announces the Acquisition of Ziath

Enhances high-throughput workflow offerings with leading 2D barcode reader BURLINGTON, Mass., Feb. 3, 2023 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that it has acquired Ziath, Ltd. and its subsidiaries

Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors

News, Management, Press Releases

SAN DIEGO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, announced today that Tina S. Nova, Ph.D. has been elected as Executive Chair of the Exagen

Azenta to participate in the 41st Annual J.P. Morgan Healthcare Conference

BURLINGTON, Mass., Jan. 5, 2023 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that Company management will participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Wednesday,

Azenta to participate in the 25th Annual Needham Growth Conference

BURLINGTON, Mass., Jan. 5, 2023 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that Company management will participate in the 25th Annual Needham Growth Conference in New York, NY, on Wednesday, January 11,

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.